Job-Hopping Lost Premium as Financial Incentives Flatten
New wage data in early 2026 shows the payoff from switching jobs is fading. Movers earned roughly 4% in January, whil...
Articles — Page 313
Iran Reviving Remote Work Sparks Global Labor Rebalancing
A regional war has unsettled energy markets, prompting a global push toward remote work. Observers say iran reviving ...
Trump’s Iran Could Hike U.S. Debt Amid Tariff Fallout
A new forecast warns that a 60-day Iran clash could push the federal deficit higher by about $65 billion, on top of t...
Trump Weighs Jones Act Waiver as Fuel Prices Rise Worldwide
The White House confirms a policy review of a temporary Jones Act waiver as oil nears $100 a barrel and fuel costs ri...
Energy Secretary Wright Says Tanker Escorts Could Launch Soon
The administration signals a possible tanker escort plan through the Strait of Hormuz, but says the Navy isn’t ready....
Traders Loading Longs Surges in XRP, Yet One Metric Warns
A wave of XRP buyers is pushing long bets higher across venues, but a troubling metric shows risk to a sustained rall...
Batton Plaintiffs Lose Intervene in Anywhere Settlement
Anywhere Real Estate gains preliminary approval for the Tuccori settlement amid a denial of the Batton plaintiffs' bi...
Trade Groups Raise Alarms Over Housing Act Ahead of Senate
As the Senate moves to vote on the ROAD to Housing Act, trade groups warn that key provisions could constrain housing...
TeraWulf Price Prediction: Pullback Sparks Investor Entry
TeraWulf (WULF) shares pull back 22% from their 52-week high, but the company’s expanding HPC footprint and Google-ba...
MercadoLibre’s $2,100 Target: Can MELI Rally in 2026?
MercadoLibre stock slid 17% in the past month as JPMorgan cut its target to $2,100, citing fierce competition and mar...
Cramer: Credo Technology Still Wins, Marvell Takes Lead
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
Merck Price Prediction: Sac-TMT Could Lift MRK to Peak
Analysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...